Heart Disease & EECP in Europe
Saturday, June 16, 2007
  Update - June 2007
Since the posts last year I have been through quite a stressful time personally - moving house in October 2006, a process involving a lot of physical work. My condition worsened and attacks of angina resumed - in retrospect induced by the excessive physical effort involved in the move ( lifting a lot of 15-20kg banana boxes filled with household bits and pieces is not the best treatment for heart disease!).

The opportunity came up to do another course of EECP in very congenial surroundings - Miami Beach, Florida - in the middle of winter December 2006- January 2007. This worked very well and a nuclear imaging scan at the end of the second course showed a near normal heart muscle, Deo gratias! Since then I have had a progressive improvement, the main problem being fatigue rather than recurrences of angina.

Recently I have started a course of D-ribose (10g/day) and this is having a salutary effect on the fatigue front. I am very well , far better than I deserve to be and am therefore a very strong advocate still for the benefits of EECP. I have been keeping up the daily measurements of BP and hope to publish graphical summaries of the data in the near future with a more detailed explanation of the ups and downs.

I hope that this will encourage others to undergo similar treatment. Because of the way that EECP operates in improving blood flow in and around the heart, the earlier you start, the better the results. Unfortunately most EECP treatments seem to given to people who already have very advanced cardiovascular disease (Canadian Classifications III and IV) where cardiologists are rather defeated by the combination of symptoms presenting to them. I have been very lucky to have been caught at an earlier stage.

HP Masher
 
For patients and professionals with an interest in coronary artery disease (CAD)and heart failure (CHF). External counterpulsation (EECP) has been a great help to many patients by reducing angina and other debilitating symptoms. Being comparatively inexpensive its use in Europe should be expanded to improve quality of life and reduce healthcare bills. Start from the bottom (oldest post) and work towards the top. Comments are welcome - Click on the 'Comments' tab at the end of each post

ARCHIVES
July 2006 / September 2006 / October 2006 / June 2007 / September 2007 / February 2008 / April 2008 / June 2008 / December 2008 / July 2009 / February 2010 / August 2010 / April 2015 /


Powered by Blogger